Long-Term Follow-up of Over 600 Living Related Kidney Donors: Single-Center Experience

• Published in: Experimental and clinical transplantation Vol. 20; no. Suppl 1; pp. 17 - 19
• Main Authors: Sayin, Burak, Akdur, Aydincan, Karakaya, Emre, Ayvazoglu Soy, Ebru H, Haberal, Mehmet
• Format: Journal Article
• Language: English
• Published: Turkey 01.03.2022
• Subjects: Adult; Cardiovascular Diseases - etiology; Follow-Up Studies; Humans; Hypertension - diagnosis; Hypertension - epidemiology; Hypertension - etiology; Kidney; Kidney Failure, Chronic - diagnosis; Kidney Failure, Chronic - epidemiology; Kidney Failure, Chronic - surgery; Kidney Transplantation - adverse effects; Kidney Transplantation - methods; Living Donors; Middle Aged; Nephrectomy - adverse effects; Obesity - complications; Quality of Life; Treatment Outcome
• ISSN: 1304-0855; 2146-8427
• DOI: 10.6002/ect.MESOT2021.O4

Kidney transplant is the treatment of choice in patients with end-stage renal disease because it offers improved survival and better quality of life. Although most epidemiologic studies have suggested that living kidney donors have a minimal lifetime risk of developing end-stage renal disease, long-term complications and physiologic and psychologic sequelae resulting from donation remain unclear. Here, we examined the long-term results of living-related kidney donors who donated kidneys at the Başkent University Ankara Hospital over the past 25 years. We were able to examine 607 kidney transplant donors (mean age of 52.03 ± 11.54 years) who were seen at our center from 1986 to 2021 and who agreed to a general health evaluation. Collected data included donor age, sex, blood type, body mass index, duration after donation, blood pressure measurements, biochemical parameters, abdominal ultrasonograph for size, structure, and renal blood flow of the solitary kidney, comorbid conditions, chronic drug use, and surgical procedures after donation. Mean time after donation was 10.4 ± 3.2 years. Twenty-four donors (3.9%) were diagnosed with diabetes and 21 (3.4%) with thyroid disease, 64 (10.5%) developed hypertension, and 48 (8.8%) developed atherosclerotic cardiovascular disease. Obesity was found to be an increasing problem in our donor population, with 174 (28.6%) developing mild to moderate obesity (body mass index >25 kg/m2). Older age, obesity, smoking, and hyperlipidemia were found to be the major and independent risk factors of both hypertension and atherosclerotic cardiovascular disease in donors. None of our donors developed endstage renal disease. Obesity and hypertension were the most common comorbidities that developed in our kidney donor population. Our principle is to avoid unrelated and nondirected donors because of the possible long-term complications. Unrelated donors may be desperate if a family member needs donation in the future.